The Role of Wnt Signalling in Chronic Kidney Disease (CKD)

被引:25
|
作者
Malik, Soniya A. [1 ]
Modarage, Kavindiya [1 ]
Goggolidou, Paraskevi [1 ]
机构
[1] Univ Wolverhampton, Fac Sci & Engn, Dept Biomed Sci & Physiol, Wulfruna St, Wolverhampton WV1 1LY, England
关键词
Wnt signalling; polycystic kidney disease; nephronophthisis; beta-catenin; planar cell polarity signalling; PLANAR CELL POLARITY; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; MOLECULAR-CLONING; BETA-CATENIN; JOUBERT-SYNDROME; PROTEIN; URETERAL OBSTRUCTION; ABERRANT ACTIVATION; WIDE ASSOCIATION; GENE;
D O I
10.3390/genes11050496
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Chronic kidney disease (CKD) encompasses a group of diverse diseases that are associated with accumulating kidney damage and a decline in glomerular filtration rate (GFR). These conditions can be of an acquired or genetic nature and, in many cases, interactions between genetics and the environment also play a role in disease manifestation and severity. In this review, we focus on genetically inherited chronic kidney diseases and dissect the links between canonical and non-canonical Wnt signalling, and this umbrella of conditions that result in kidney damage. Most of the current evidence on the role of Wnt signalling in CKD is gathered from studies in polycystic kidney disease (PKD) and nephronophthisis (NPHP) and reveals the involvement of beta-catenin. Nevertheless, recent findings have also linked planar cell polarity (PCP) signalling to CKD, with further studies being required to fully understand the links and molecular mechanisms.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Novel biomarkers in kidney disease: roles for cilia, Wnt signalling and ATMIN in polycystic kidney disease
    Goggolidou, Paraskevi
    Wilson, Patricia D.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 1745 - 1751
  • [32] Prediction of Chronic Kidney Disease (CKD) in People with Diabetes
    Afshar, Nader
    Huschto, Tony
    Andorra, Magi
    Chittajallu, Siva
    Ringemann, Christian
    Odegard, John T.
    Mikulski, Heather
    Babinsky, Valerie N.
    Konig, Helena
    Singh, Inderjit
    DIABETES, 2021, 70
  • [33] Costs of chronic kidney disease (CKD): Cost and comorbidity
    Smith, DH
    Gullion, C
    Nichols, G
    Keith, D
    Brown, J
    VALUE IN HEALTH, 2002, 5 (06) : 581 - 581
  • [34] Prevalence of Chronic Kidney Disease (CKD) in Lymphoma Survivors
    Al-Shbool, Ghassan
    Desale, Sameer
    Veis, Judith
    Malkovska, Vera
    Desai, Sanjal
    BLOOD, 2019, 134
  • [35] Monogenic and polygenic concepts in chronic kidney disease (CKD)
    Julia Jefferis
    Rebecca Hudson
    Paul Lacaze
    Andrew Bakshi
    Carmel Hawley
    Chirag Patel
    Andrew Mallett
    Journal of Nephrology, 2024, 37 : 7 - 21
  • [36] Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective
    Lohia, Sonnal
    Vlahou, Antonia
    Zoidakis, Jerome
    TOXINS, 2022, 14 (03)
  • [37] Chronic kidney disease: The effect of age on CKD outcomes
    Allison S.J.
    Nature Reviews Nephrology, 2013, 9 (1) : 3 - 3
  • [38] Vitamin D and methylarginines in chronic kidney disease (CKD)
    Torino, Claudia
    Pizzini, Patrizia
    Cutrupi, Sebastiano
    Tripepi, Rocco
    Tripepi, Giovanni
    Mallamaci, Francesca
    Zoccali, Carmine
    PLOS ONE, 2017, 12 (10):
  • [39] Vitamin D resistance in chronic kidney disease (CKD)
    Amay Parikh
    Herbert S Chase
    Linda Vernocchi
    Leonard Stern
    BMC Nephrology, 15
  • [40] Predicted prevalence in Japan of chronic kidney disease (CKD)
    Genjiro Kimura
    Clinical and Experimental Nephrology, 2007, 11 (2) : 188 - 189